Narrow Results

Efficient Light-Harvesting of Plants: Conversation with Professor Alexander Ruban.

Takeda Pharmaceuticals in the Emerging Markets.

Burden of Thrombosis-related Diseases in Asia-Pacific.

GE Healthcare's Cell Culture Media Facility in Singapore.

Waste Management in Singapore: Where Does Our Rubbish Go?

BIOTRONIK Begins Manufacturing High-Tech Products in Singapore.

First Dengue Vaccine Approved in More than 10 Countries.

Zyrtec^® Tablet for Allergy Relief, Now Available Over-the-Counter as Zyrtec^®-R Tablet.

Covance Receives Frost & Sullivan Asia Pacific CRO Growth Excellence Leadership Award Three Years Running.

First Pan-Asian Real-world Study on the Use of Rivaroxaban for Stroke Prevention in Patients with Atrial Fibrillation.

Oxford Spinout to Develop Cancer Therapies which Reprogram Tumours to Die.

Recruitment Begins for Major Clinical Study in Precision Therapy for Liver Cancer Patients.

GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea.

Vascular Dynamics receives FDA approval to begin conclusive and pivotal trial experimentation for treatment of chronic hypertension.

Orchard Therapeutics’ OTL-101 granted Promising Innovative Medicine Designation for treatment of ADA-SCID.

Concept Life Sciences appoints John Handley as chief operating officer.

Oak Therapeutics completes Phase 1 of NIH grant to develop formulation for tuberculosis.

Relvar Ellipta significantly improves asthma control compared with usual care medicines.

Hematological disorders to benefit from significant level of first-in-class innovation.

Boehringer Ingelheim initiates Phase IIa study of Pharmaxis compound for treating NASH.

Ambrosus partners with Trek Therapeutics to develop blockchain method to track quality in pharmaceutical manufacturing.

Bosch subsidiary Valicare offers consulting in GMP-compliant development of cancer therapies.

Korea-Singapore Healthcare Incubator to support Korean firms in Singapore and Southeast Asia.

Newer oral anticoagulant recommended for reducing risk of stroke in patients with irregular heartbeats.

Korean start-up Sky Labs selected as one of the winners for Bayer Grants4Apps Accelerator.

Supplement: Could COMPASS be a game changer in managing stable artery disease?

Supplement: Global study confirms positive benefit-risk profile of rivaroxaban for stroke prevention.